- News
News
Glasgow Tech Week to showcase local tech, digital, and creative industries
Entrepreneurs and innovators from across Scotland’s largest city are set to gather next month for the first-ever Tech Week in Scotland.
More
- News
News
Strathclyde spinout aims to tackle global warming with legal knowledge hub
The University of Strathclyde’s first-ever social enterprise spin-out company – C2LI – aims to tackle global warming by helping private and public sector organisations understand and adhere to climate change-related law.
More
- News
News
World unique research hub set to transform the global forging sector
The world’s most advanced research and innovation hot forging platform is opening today (21st March) at the University of Strathclyde’s Advanced Forming Research Centre (AFRC), part of the National Manufacturing Institute Scotland
More
- News
News
Strathclyde cyber security research group earns prestigious centre of excellence status
StrathCyber, the Cyber Security Research Group at the University of Strathclyde has gained Academic Centre of Excellence status from the UK Government.
More
- News
News
Strathclyde student entrepreneurs win award for innovative marketplace idea
An idea to create a marketplace for students to stop wastage of educational resources took top prize at a Strathclyde pitching contest.
More
- News
News
Strathclyde’s £1M project innovates antimicrobial drugs from food by-products
Scientists will use food by-products to make antimicrobial drugs from bacteria, in research led at the University of Strathclyde in collaboration with the University of Surrey and GSK.
More
- News
News
Strathclyde Business School launches scale-up initiative with Scottish National Investment Bank
A new programme to address the growth barriers faced by Scottish businesses attempting to scale-up has launched.
More
- News
News
Strathclyde researchers to develop preclinical lead drug for advanced prostate and colorectal cancers
Researchers at the University of Strathclyde have been awarded £2.6 million to develop a preclinical lead drug candidate targeted at advanced prostate and colorectal cancers.
More